Can-Fite BioPharma (CANF) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Can-Fite BioPharma Ltd. has announced an inducement offer for warrant holders to exercise their purchase rights of ordinary shares represented by American Depositary Shares at a price of $1.75. In return, the company is offering new warrants with an exercise price of $2.25, which are exercisable between 20 months to five years, depending on the terms. These new warrants and any underlying shares will initially be unregistered and subject to certain restrictions.
For further insights into CANF stock, check out TipRanks’ Stock Analysis page.

